Financhill
Back

Adagene 10K Form

Buy
76

ADAG
Adagene

Last Price:
2.84
Seasonality Move:
-3.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADAG News And Ratings

See the #1 stock for the next 7 days that we like better than ADAG

ADAG Financial Statistics

Sales & Book Value

Annual Sales: $18.11M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.60
Price / Book: 1.77

Profitability

EPS (TTM): -0.43750
Net Income (TTM): $-18.95M
Gross Margin: --
Return on Equity: -24.04%
Return on Assets: -14.09%

Adagene Earnings Forecast

Key Adagene Financial Ratios

  • The Research & Development expenses have been 202.30% of Revenue.
  • The Interest Expense is -5.85% of Operating Income.
  • The Net Earning history of ADAG is -104.61% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Adagene Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADAG
Website: adagene.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 3.61
Quick Ratio: 3.5

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADAG Technical Analysis vs Fundamental Analysis

Buy
76
Adagene (ADAG) is a Buy

Is Adagene a Buy or a Sell?

  • Adagene stock is rated a Buy
    The current Adagene [ADAG] share price is $2.83. The Score for ADAG is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.